Injecting too much insulin causes blood sugar to plummet, a condition called hypoglycemia that can progress from mild shakiness to seizures, dangerous heart rhythms, and death if not corrected. The severity depends on how much excess insulin enters the body, how quickly it acts, and whether the person’s natural defense systems can mount a response. What makes insulin overdose particularly treacherous is that the damage extends well beyond low blood sugar itself, affecting the heart, brain, and electrolyte balance in ways that require careful, sometimes prolonged medical management.
The Immediate Blood Sugar Crash
Insulin’s job is to shuttle glucose out of the bloodstream and into cells. When too much is injected, that process goes into overdrive, and blood sugar drops faster than the body can compensate. The first symptoms tend to appear as glucose falls below about 3.8 mmol/L (roughly 70 mg/dL) in people without diabetes, though the exact threshold varies. The early warning signs are driven by a surge of adrenaline: trembling hands, a pounding heart, sweating, and intense hunger. These feel unpleasant, but they serve a purpose. They are the body’s alarm system telling you to eat something.
If blood sugar keeps falling and nothing is done, symptoms shift from uncomfortable to dangerous. Confusion sets in. Speech slurs. Coordination breaks down. Below about 2.5 mmol/L (45 mg/dL), the brain starts running out of fuel, and seizures or loss of consciousness can follow. In a study of non-diabetic and diabetic subjects whose blood sugar was held at 2.5 mmol/L for 30 minutes, nine out of ten people without diabetes recognized they were hypoglycemic, but only four out of fifteen people with diabetes did.1PubMed. Influence of sympathetic nervous system on hypoglycaemic warning symptoms That gap in awareness is one of the most dangerous aspects of insulin therapy, and it becomes especially relevant when someone has received too much.
The Body’s Counter-Regulatory Defense and How It Fails
A healthy body does not passively accept falling blood sugar. It activates a set of counter-regulatory hormones to push glucose back up. Glucagon from the pancreas signals the liver to dump stored glucose. Adrenaline and cortisol mobilize additional fuel. Growth hormone chips in. Together, these hormones can pull a person out of a mild low without any outside help.
The problem is that this system degrades in people who use insulin regularly, especially those who experience frequent lows. A systematic review found that in people with type 1 diabetes, the glucose thresholds at which adrenaline, cortisol, and growth hormone kick in were all significantly lower than in people without diabetes.2PubMed Central. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review In practical terms, their bodies wait longer to sound the alarm, which means blood sugar falls further before any rescue response begins. Intensive insulin therapy itself contributes to this blunting: one study of patients on insulin pump treatment found significant reductions in adrenaline, growth hormone, and cortisol release during hypoglycemia compared to before pump therapy, and the already-defective glucagon response was not corrected.3PubMed. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes
Repeated episodes of hypoglycemia also make the problem worse over time. This creates a vicious cycle: tight glucose control leads to more lows, which blunt the counter-regulatory response, which leads to deeper and more dangerous lows.4PubMed Central. Glucose counterregulatory responses to hypoglycemia Someone in this cycle who accidentally injects too much insulin is far more vulnerable than someone experiencing their first hypoglycemic episode.
Hypoglycemia Unawareness
The blunting of counter-regulatory hormones does more than weaken the body’s glucose recovery. It also strips away the warning symptoms that tell a person they are going low. This condition, known as hypoglycemia unawareness, means a person can slide from normal blood sugar into dangerously low territory without feeling anything at all. The sympathoadrenal activation that produces sweating, trembling, and anxiety becomes impaired by repeated episodes of tight glycemic control and recurrent hypoglycemia, leading to a high risk of severe episodes.5The British Journal of Diabetes & Vascular Disease. Hypoglycaemia: Its pathophysiology in insulin treated diabetes and hypoglycaemia unawareness
For someone with hypoglycemia unawareness, an insulin overdose is especially perilous because the window between “fine” and “unconscious” can be very narrow. They may not realize anything is wrong until a family member finds them unresponsive. This is a major reason why continuous glucose monitoring technology has become increasingly important for people on intensive insulin regimens.
What Happens to the Heart
One of the less obvious but most life-threatening consequences of an insulin overdose is what it does to the heart. As blood sugar drops, the surge of adrenaline and the resulting shift of electrolytes create conditions ripe for abnormal heart rhythms. Insulin drives potassium from the bloodstream into cells, and during severe hypoglycemia, potassium levels can fall substantially. In a study using both diabetic and non-diabetic rats, potassium dropped from around 4.0–4.2 mmol/L to roughly 2.9 mmol/L during severe hypoglycemia, and supplementing potassium reduced mortality from severe hypoglycemia notably in both groups.6Diabetes. Severe Hypoglycemia–Induced Lethal Cardiac Arrhythmias Are Mediated by Sympathoadrenal Activation
In human studies, acute hypoglycemia causes prolongation of the QT interval on an electrocardiogram, a marker of increased arrhythmia risk. One controlled study found QT interval prolongation of about 31–39 milliseconds during hypoglycemia in both people with type 2 diabetes and controls, along with a significant increase in premature ventricular beats in both groups.7PubMed Central. Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls Premature ventricular beats are usually harmless in isolation, but during the metabolic stress of severe hypoglycemia, they can deteriorate into ventricular fibrillation, a lethal rhythm. After a massive overdose, the rebound phase carries its own cardiac risk: once the insulin effect wears off and potassium shifts back out of cells, abnormally high potassium can trigger arrhythmias all over again.8PubMed Central. A Case Involving Massive Insulin Overdose: Direct and Indirect Conditions Requiring Extended Management of Serum Potassium
What Happens to the Brain
The brain is the organ most immediately vulnerable to low blood sugar because it relies almost exclusively on glucose for fuel. Hypoglycemia commonly causes what researchers call functional brain failure: confusion, impaired judgment, strange behavior, slurred speech, seizures, and eventually coma. The critical distinction is that functional brain failure reverses once glucose is restored. Raise blood sugar back to normal, and the brain comes back online.9PubMed Central. Hypoglycemia, functional brain failure, and brain death
Rarely, though, profound and prolonged hypoglycemia can cross a threshold into permanent brain damage. This is not simply fuel deprivation running its course. The mechanisms behind irreversible injury involve excitotoxicity, oxidative stress, and neuronal death in vulnerable brain regions. Animal research has shown that the hippocampus, the brain region critical for memory, is particularly susceptible. Rats subjected to recurrent severe hypoglycemia showed memory impairment, neuron loss concentrated in the hippocampus (especially the dentate gyrus), and an increase in reactive astrocytes indicating ongoing inflammation.10PubMed Central. Effect of recurrent severe insulin-induced hypoglycemia on the cognitive function and brain oxidative status in the rats
There is an interesting wrinkle here. Research suggests that moderate recurrent hypoglycemia may paradoxically make the brain somewhat more resistant to the damage caused by a single severe episode, similar to preconditioning effects seen in other organs. That adaptation makes a person more likely to experience severe hypoglycemia (due to blunted awareness) but potentially less vulnerable to brain injury when it happens.11The Journal of Clinical Investigation. Recurrent hypoglycemia: boosting the brain’s metabolic flexibility This does not mean frequent lows are protective. It means the relationship between hypoglycemia and brain damage is more complex than “every low kills neurons.”
How an Insulin Overdose Is Treated
If someone is conscious and able to swallow, the first response is simple: fast-acting sugar. Juice, glucose tablets, candy. But in a serious overdose, especially an intentional one involving hundreds or thousands of units, oral sugar is nowhere near sufficient. Hospital treatment starts with an intravenous dextrose bolus to rapidly bring blood sugar above the danger zone, followed by a continuous dextrose infusion aimed at keeping glucose between roughly 5.5 and 11 mmol/L (100–200 mg/dL).12PubMed Central. Treatment of sulfonylurea and insulin overdose
The tricky part is duration. Insulin absorption and effects vary enormously between individuals and between insulin types, and clinicians must tailor glucose infusion rates to each situation because of this variability.13Annals of Emergency Medicine. Intentional massive insulin overdose: Recognition and management A massive dose of a long-acting insulin can cause hypoglycemia that drags on for days. In one striking case, a 26-year-old man injected 4,800 units of glargine (a long-acting insulin analogue). He required about 800 grams of dextrose per day, and the glucose supplementation itself caused acute liver injury. On the fourth day, surgeons excised a depot of insulin that had formed under the skin of his abdomen. Only after that did his glucose requirements drop and his liver function improve.14Diabetic Medicine. Acute hepatic injury following treatment of a long-acting insulin analogue overdose necessitating urgent insulin depot excision
Glucagon, a hormone that opposes insulin by stimulating the liver to release stored glucose, is another tool. Injectable and intranasal glucagon kits are available for emergency use outside the hospital. A systematic review comparing glucagon to intravenous dextrose found similar effectiveness for treating hypoglycemic episodes, though dextrose is preferred when IV access is available because it works faster and more predictably.15PubMed. Glucagon for hypoglycemic episodes in insulin-treated diabetic patients: a systematic review and meta-analysis Glucagon’s real value is for bystanders who find someone unconscious and cannot start an IV. It buys time until paramedics arrive.
Why Kidney Disease Raises the Risk
Your kidneys play an underappreciated role in insulin metabolism. They help clear insulin from the blood and contribute to gluconeogenesis, the process of making new glucose. When kidney function is impaired, insulin hangs around longer, and the kidneys produce less glucose to counteract a low. People with diabetic kidney disease face a triple threat: decreased insulin clearance, reduced kidney-based glucose production, and altered drug metabolism.16PubMed Central. Interactions between kidney disease and diabetes: dangerous liaisons A dose that was safe when kidney function was normal may become an overdose as kidney disease progresses, which is why insulin doses often need to be reduced as kidney function declines.
Interestingly, in cases where high-dose insulin is given intentionally as a medical treatment (for certain types of drug poisoning), one case series found that insulin’s elimination half-life was relatively short and was not significantly affected by kidney disease or by the dose given.17PubMed. Serial insulin and C-peptide concentrations following high-dose insulin for the treatment of drug poisoning The clinical picture of insulin clearance may be more nuanced than older models suggested, and individual variation likely matters more than any single risk factor.
The Rebound Effect
After blood sugar crashes from too much insulin, it sometimes swings the other direction. The counter-regulatory hormones that the body releases in response to hypoglycemia, particularly glucagon and adrenaline, can overshoot, driving the liver to dump glucose into the bloodstream and causing a period of high blood sugar afterward. This phenomenon, sometimes called the Somogyi effect or posthypoglycemic hyperglycemia, can confuse the clinical picture. Research has confirmed that hypoglycemia can cause rebound hyperglycemia through excessive activation of glucose counter-regulatory systems, even when insulin levels have not dropped.18PubMed. Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia)
For someone managing diabetes day to day, this rebound can create a frustrating pattern: a nighttime low triggers a morning high, which looks like the insulin dose was too small, tempting the person to increase their dose, which causes more lows. Recognizing the pattern requires checking blood sugar during the night or using continuous glucose monitoring to catch the overnight drop.
Insulin Misuse Outside of Diabetes
Not all insulin overdoses happen in people with diabetes. Insulin has a long history of misuse in several contexts. Some bodybuilders use insulin as a performance-enhancing drug, believing it promotes muscle growth by driving amino acids and glucose into muscle cells. Research on recreational bodybuilders who used insulin found distinct metabolic consequences, including elevated liver enzymes and altered lipid profiles, separate from the effects of anabolic steroids.19PubMed Central. Metabolic Consequences of Anabolic Steroids, Insulin, and Growth Hormone Abuse in Recreational Bodybuilders These individuals are dosing a powerful hormone without medical supervision, glucose monitoring, or any safety net, which makes accidental severe hypoglycemia a real and sometimes fatal risk.
Intentional insulin overdose as a means of self-harm is another sobering reality. Insulin-induced hypoglycemia accounts for a substantial number of emergency department visits each year, and up to 90% of patients who present to toxicology wards with insulin overdoses did so intentionally. People with diabetes carry a two to three times higher risk of depression compared to the general population, and the accessibility of insulin makes it a tragically convenient means of self-harm.20PubMed Central. The Other Face of Insulin-Overdose and Its Effects
Pump Technology and Overdose Prevention
Modern insulin pump technology has introduced automated safeguards that reduce the risk of accidental overdose. Systems that combine continuous glucose monitors with insulin pumps can detect falling blood sugar trends and automatically reduce or suspend insulin delivery before glucose drops to dangerous levels. One outpatient study of a predictive low-glucose suspend system found it reduced nocturnal hypoglycemia by almost half.21PubMed Central. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia
A larger randomized trial of a suspend-before-low pump system in adults prone to hypoglycemia found even more dramatic results: the intervention group experienced about one hypoglycemic event per week compared to four in the control group, and severe episodes requiring third-party assistance dropped from eighteen to three over the study period.22The Lancet Diabetes & Endocrinology. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE) These systems are not foolproof. They cannot prevent someone from manually bolusing a large dose or injecting insulin separately with a syringe. But for the everyday risk of gradual accidental over-insulinization, especially overnight, the technology has been genuinely transformative. Ongoing development aims to further integrate glucose monitoring with automated insulin dosing to minimize dangerous swings in both directions.23PubMed Central. Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review
Forensic Detection of Insulin Overdose
Diagnosing an insulin overdose in a living patient is relatively straightforward: low blood sugar with high insulin levels and suppressed C-peptide (a molecule released in equal amounts when the body makes its own insulin, but absent when the insulin came from a syringe). In forensic cases involving a death, the diagnosis is much harder. Insulin degrades rapidly after death, and the normal postmortem biochemical chaos makes standard blood tests unreliable.
Forensic researchers have established that the ratio of insulin to C-peptide in a corpse can serve as positive evidence of exogenous insulin overdose. Because injected insulin raises insulin levels without raising C-peptide, a disproportionately high insulin-to-C-peptide ratio points to an outside source.24PubMed. The ratio of insulin to C-peptide can be used to make a forensic diagnosis of exogenous insulin overdosage This technique has been used in criminal investigations where insulin injection was suspected as a cause of death. It remains one of the few reliable postmortem markers available, though it requires careful sample handling and interpretation by specialists familiar with the limitations of postmortem biochemistry.